47
In band
Moving averages
SMA 200$4.73+44.61%
Company profile
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$335.55M
P/E ratio2.937
EPS$2.53
Beta1.324
Dividend yield0.00%
52-week high$10.31
52-week low$2.71
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
ARTV
Artiva Biotherapeutics Inc
RSI 21
ARCT
Arcturus Therapeutics Holdings Inc
RSI 45
OCGN
Ocugen Inc
RSI 29
EDIT
Editas Medicine Inc
RSI 51
CAPR
Capricor Therapeutics Inc
RSI 42
ALLO
Allogene Therapeutics Inc
RSI 29
RSI alerts for AGEN
An email when AGEN closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:48 PM EDT